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Mitogen-activated protein kinase (MAPK) cascades control cell fate decisions, such as pro-
liferation, differentiation, and apoptosis by integrating and processing intra- and extracellular
cues. However, similar MAPK kinetic profiles can be associated with opposing cellular deci-
sions depending on cell type, signal strength, and dynamics. This implies that signaling by
each individual MAPK cascade has to be considered in the context of the entire MAPK
network. Here, we develop a dynamic model of feedback and crosstalk for the three major
MAPK cascades; extracellular signal-regulated kinase (ERK), p38 mitogen-activated protein
kinase (p38), c-Jun N-terminal kinase (JNK), and also include input from protein kinase B
(AKT) signaling. Focusing on the bistable activation characteristics of the JNK pathway, this
model explains how pathway crosstalk harmonizes different MAPK responses resulting in
pivotal cell fate decisions. We show that JNK can switch from a transient to sustained
activity due to multiple positive feedback loops. Once activated, positive feedback locks
JNK in a highly active state and promotes cell death. The switch is modulated by the ERK,
p38, and AKT pathways. ERK activation enhances the dual specificity phosphatase (DUSP)
mediated dephosphorylation of JNK and shifts the threshold of the apoptotic switch to
higher inputs. Activation of p38 restores the threshold by inhibiting ERK activity via the
PP1 or PP2A phosphatases. Finally, AKT activation inhibits the JNK positive feedback, thus
abrogating the apoptotic switch and allowing only proliferative signaling. Our model facili-
tates understanding of how cancerous deregulations disturb MAPK signal processing and
provides explanations for certain drug resistances. We highlight a critical role of DUSP1
and DUSP2 expression patterns in facilitating the switching of JNK activity and show how
oncogene induced ERK hyperactivity prevents the normal apoptotic switch explaining the
failure of certain drugs to induce apoptosis.
Keywords: dynamic model, bistability, JNK mitogen-activated protein kinases, Akt (PKB), dual specificity phos-
phatase
1. INTRODUCTION
A hallmark of cancer is dysregulation of pivotal cell fate decisions
leading to aberrant proliferation and reduced apoptosis (Hana-
han and Weinberg, 2011). Healthy cell fate decisions depend on a
proper sensing of the cell’s intra- and extracellular environment
in a process called signal transduction (Kholodenko et al., 2010).
The signals are sensed by receptors that bind their cognate extra-
cellular ligands, resulting in conformational changes that trigger
the formation of multi-protein complexes and subsequent activa-
tion of GTPases and kinases (Lemmon and Schlessinger, 2010).
Hereby, one receptor usually activates several downstream path-
ways. Main transducers are MAPK cascades, which consist of a lin-
ear array of three kinases where a GTPase activates a MAPK kinase
kinase (MAPKKK; MAP3K), which phosphorylates and activates
a MAPK kinase (MAPKK; MAP2K), which in turn activates a
MAPK that delivers the main pathway output by phosphorylation
of multiple substrates (Kolch, 2005; Dhillon et al., 2007). MAPKs
and MAP2Ks are activated by dual phosphorylation, which can
confer switch like properties to the activation kinetics (Kholo-
denko, 2000). Sometimes a MAP4K is intercalated between the
GTPase and the MAP3K. A particular cell fate cannot be attrib-
uted to the activity of a single protein in isolation, but rather
depends on the context, including the temporal patterns of acti-
vation and the regulatory feedback structures within the signaling
network (Kholodenko, 2006; Kholodenko et al., 2010; Nakakuki
et al., 2010). Because of this complexity, the function of cellular
signaling often eludes a naive intuitive understanding, thus calling
for the use of mathematical modeling and analysis (Kitano, 2002,
2010; Ireton et al., 2009). Whereas others approach the problem
from a less mechanistic viewpoint using regression (Miller-Jensen
et al., 2007) or Boolean and semi-logic models (Saez-Rodriguez
et al., 2009, 2011), we focus on dynamic models using ordinary
differential equations.
Dynamic modeling has played a key role in understanding how
signaling via the ERK cascade regulates cell fate (Kholodenko et al.,
2010; Sturm et al., 2010). A classic example is growth factor signal-
ing in Rat Pheochromocytoma (PC12) cells, where treatment with
epidermal growth factor (EGF) or nerve growth factor (NGF) acti-
vates the same signaling cascade (the RAF/MEK/ERK cascade) but
has different effects on cell fate. EGF causes transient activation
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of ERK and proliferation due to negative feedback, whereas NGF
causes sustained ERK activation and differentiation due to positive
feedback (Santos et al., 2007; von Kriegsheim et al., 2009). Sim-
ilarly, the stress activated MAPKs JNK and p38 mediate diverse
cellular responses. For example, growth factor induced, transient
activation of JNK promotes cell survival and proliferation, whereas
stress induced, prolonged JNK activity promotes growth arrest
and cell death (Ventura et al., 2006). However, the mechanistic
details of how this switch is generated and the factors determining
the shift from proliferative to apoptotic JNK signaling are poorly
understood, and mathematical modeling and analysis is largely
lacking for stress activated kinases (Bagowski and Ferrell, 2001;
Wagner and Nebreda, 2009).
Here, we provide a dynamic model of feedback and crosstalk
for the three major MAPKs (ERK, p38, JNK) and protein kinase
B (AKT) signaling. The model incorporates mechanistic details
of positive feedback from JNK to its own MAP3Ks and negative
crosstalk from and to other pathways. Using mathematical analysis,
the model is used to decipher how JNK switches from proliferative
to apoptotic signaling and how that switch is regulated by pathway
crosstalk.
2. RESULTS
We present a dynamic model of multiple MAPK cascade inter-
actions featuring a JNK positive feedback loop that generates
a proliferative-apoptotic switch. Further, we present a detailed
analysis of factors controlling the dynamic properties of the JNK
switch, with a particular focus on feedback loops and crosstalk.
2.1. NOMINAL MODEL OF MAPK INTERACTIONS
Although MAPK signaling cascades have been studied extensively,
the connectivity of MAPK systems is not completely understood.
MAPKs feature several isoforms, a high number of inputs in the
form of different GTPases and protein kinases, several scaffolding
proteins that channel incoming signals into different pathways
and a variety of phosphatases that modulate MAPK activation
dynamics. Thus, depending on the expression and activity states
of these proteins, MAPK connections change between cell types
and in response to pathological aberrations. In order to analyze the
kinetic behavior and regulation of MAPK cascades we constructed
a model which represents a core network of MAPK interactions
based on the available literature. The topology of this model is
depicted in Figure 1.
Generally, MAPK systems are arranged in three tiered cas-
cades consisting of MAPKs (lowest tier), MAPK kinases (MAP2Ks,
second tier), and MAPK kinases kinases (MAP3Ks, top tier). Acti-
vation of the kinases in each tier is modeled with double phospho-
rylation cycles as described in Material and Methods (Sec. 5), in
which the upstream kinase acts as the enzyme catalyzing the phos-
phorylation and therefore activation of the downstream kinase.
Complementing the classical cascades, the model features sev-
eral crosstalks and feedbacks (Table 1). First, JNK phosphorylates
and activates its own MAP3K (Schachter et al., 2006; Furuhata
et al., 2009), generating a positive feedback loop. Second, p38
inhibits ERK activity by enhancing MEK dephosphorylation either
via transcriptional upregulation or phosphorylation of protein
phosphatase 2 (PP2A; Westermarck et al., 2001; Li et al., 2003;
Liu and Hofmann, 2004; Grethe and Pörn-Ares, 2006; Junttila
et al., 2008). Third, ERK inhibits JNK via induction of dual speci-
ficity phosphatases (DUSPs) catalyzing the dephosphorylation of
JNK (Paumelle et al., 2000; Monick et al., 2006). Finally, AKT
inhibits JNK activity by phosphorylating inhibitory sites in the
JNK-MAP3Ks and -MAP2Ks (Kim et al., 2001; Park et al., 2002;
Barthwal et al., 2003).
In the following section we review experimental evidence for
each crosstalk mechanism and show how they are implemented
in the dynamic model. Finally, we explore the intricate kinetic
behavior and dynamics of three MAPK cascades.
FIGURE 1 | Scheme of the nominal MAPK interaction model. For simplicity
of illustration, the double phosphorylation of MAP(K) kinases are depicted in
single steps and the three inactive forms of ASK/MLK and MKK4/7 are lumped
into one component. Ui denote inputs that are modeled as time-dependent
functions (not modeled with differential equations). Black: nominal cascades;
Blue: positive feedback from JNK to its own MAP3Ks; Red: negative crosstalk
from AKT to JNK signaling; Purple: negative crosstalk from p38 to ERK
signaling only occurring in non-transformed cells. Lower- and upper-case letter
indicate mRNAs and proteins, respectively. Single and double asterisk
indicate single- and double-phosphorylated active forms, respectively.
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Table 1 | Crosstalks and feedbacks in the nominal MAPK interaction model.
Interaction Mechanism Comments Reference
JNK → ASK1 Oligomerization and auto-phosphorylation Via JNK induced ROS production (WEHI-231) Furuhata et al. (2009)
→ MLK3 Phosphorylation Direct JNK mediated phosphorylation (HEK
293, Hela, MCF-7)
Schachter et al. (2006)
p38 a ERK Upregulation of PP2A Only in non-immortalized, non-transformed
cells
Westermarck et al. (2001), Li et al.
(2003), Liu and Hofmann (2004),
Grethe and Pörn-Ares (2006),
Junttila et al. (2008)
ERK a JNK Induction of DUSP4 and DUSP16 MDCK epithelial cells, human alveolar
macrophages
Paumelle et al. (2000), Monick et al.
(2006)
AKT a ASK1 Phosphorylation at S83 HEK293, L929 Kim et al. (2001)
a MLK3 Phosphorylation at S674 HepG2 Barthwal et al. (2003)
a MKK4 Phosphorylation at S78 HEK293T Park et al. (2002)
JNK a ERK, p38 Induction of DUSPs via Jun gene
transcription, DUSP2 is the speculative
isoform assumed in the model
What DUSP isoforms are involved is unclear;
DUSP1, 4, 6 were not detected in COS-7
Chu et al. (1996), Black et al. (2002),
Shen et al. (2003), Stepniak et al.
(2006), Junttila et al. (2008), Peng
et al. (2009)
The list comprises core interactions which are supposedly conserved between cell lines, but with the p38-ERK crosstalk being restricted to non-transformed cells.
The comments column indicates the experimental system (cell lines) used to identify the links.
2.1.1. JNK positive feedback
Several studies support the idea of a JNK positive feedback loop
on the systems level. For example, JNK positive feedback was crit-
ical for a proper stress response of Xenopus oocytes (Bagowski
and Ferrell, 2001). In mammalian cells, JNK exhibited all-or-none
responses on the single cell level after treatment with anisomycin
or sorbitol (Bagowski et al., 2003), and a positive feedback loop
was suggested (Bagowski et al., 2003; Xiong and Ferrell, 2003). On
the population level, these all-or-none responses manifest highly
ultrasensitive behavior with apparent Hill coefficients as high as
9 or 10 (Table 2), which is consistent with the presence of a pos-
itive feedback loop, which increases the degree of ultrasensitivity
(Bagowski et al., 2003).
The literature contains considerable evidence supporting the
existence of positive feedback from JNK to its own MAP3Ks, in
particular to mixed linage kinases (MLK) and apoptosis regulated
kinases (ASK; Xu and Cobb, 1997; Phelan et al., 2001; Ventura
et al., 2004; Schachter et al., 2006; Furuhata et al., 2009). For
example, in HEK 293, Hela and MCF-7 cells, JNK phosphory-
lated MLK3 directly at sites in the COOH-terminal region, which
resulted in the redistribution of MLK3 to triton-insoluble mem-
brane microdomains, increased phosphorylation of the activation
loop and increased MLK3 activity (Schachter et al., 2006). Simi-
larly in COS-7 cells, JNK phosphorylated the C-terminal domain
of MLK2, which was required for MLK2-induced apoptosis (Phe-
lan et al., 2001). Further, JNK phosphorylated a MEKK1 fragment
in vitro and coimmunoprecipitated with MEKK1 in HEK 293 cells
(Xu and Cobb, 1997). MEKK1 is a MAP3K for the JNK pathway,
which depending on its phosphorylation status, also can act as
a scaffold for the MEKK1-MKK4-JNK pathway (Gallagher et al.,
2002).
Another, more indirect route of JNK feeding back to its own
MAP3Ks involves the production of reactive oxygen species (ROS).
In fibroblasts, JNK produced ROS after TNF treatment, in a process
Table 2 | Ultrasensitivity of the JNK response to stress in mammalian
cell populations (Bagowski et al., 2003).
Stimulus Apparent Hill Coefficient
HeLa HEK293 Jurkat
Sorbitol 9 8 4
Anisomycin 10 4 3
that did not involve gene transcription and was inhibited by NF-
κB (Ventura et al., 2004). Interestingly, several signaling pathways
connect ROS to JNK activation, suggesting a JNK-ROS positive
feedback loop (Shen and Liu, 2006). ASK1 in particular is readily
activated by ROS, whereby ROS induces the dissociation of ASK
from internal inhibitors such as thioredoxin or 14-3-3 proteins,
finally resulting in ASK1 oligomerization and phosphorylation of
its activation loop (Saitoh et al., 1998; Goldman et al., 2004; Shen
and Liu, 2006). In fact, such a ROS dependent positive feedback
loop has been reported in WEHI-231 mouse B lymphoma cells,
where JNK activity produced hydrogen peroxide (H2O2) which,
in turn, activated ASK1 (Furuhata et al., 2009).
The molecular mechanisms of MAP3K activation are quite
complex. For example, MLK3 activation involves GTPases bind-
ing, translocation to the membrane, dimer- or oligomerization,
and activation loop phosphorylation of MLK3 at Thr2277 and
Ser281 (Schachter et al., 2006). Neglecting this complexity, and
in concordance with earlier models in the literature, we model the
activation of MAP3Ks as a phosphorylation process catalyzed by its
inputs (Kholodenko, 2000; Kholodenko et al., 2010). In the model,
different JNK-MAP3Ks are lumped into one ASK/MLK compo-
nent. The activation of this component is modeled as a double
phosphorylation cycle with two inputs, representing the activity
of upstream GTPases u3 and active JNK (see Figure 1). Although
www.frontiersin.org September 2012 | Volume 3 | Article 355 | 3
Fey et al. MAPK crosstalk and signalling switches
our model simplifies the involved molecular events, it captures the
main feature of MAP3K activation, namely the phosphorylation
of two conserved residues in the activation loop.
2.1.2. p38 inhibits ERK signaling in non-transformed cells
Generally, ERK activity promotes survival. The suppression of
this activity by p38 is critical for induction of apoptosis in non-
transformed cells and PP2A mediates this effect (Junttila et al.,
2008). In particular, p38 mediated dephosphorylation of MEK was
necessary for arsenite induced apoptosis in human skin fibrob-
lasts (HSF) and rat primary neurons (CGN), but not in trans-
formed and tumorigenic cell lines (HeLa, Jurkat, K562, HT-1080,
WM266-4, A2058; Li et al., 2003). Further, PP2A mediated this
p38-MEK negative crosstalk and was required for both cytokine
and stress induced apoptosis in human endothelium cells and
rat cardiac ventricular myocytes, respectively (Liu and Hofmann,
2004; Grethe and Pörn-Ares, 2006).
How p38 regulates PP2A is uncertain. PP2A is a heterotrimer
composed of a scaffold, a catalytic subunit and different regulatory
subunits. Its catalytic activity can be regulated on several levels,
including assembly of the heterotrimer with different regulatory
subunits, and both phosphorylation or methylation of the catalytic
subunit (Janssens and Goris, 2001; Nguyen et al., 2012). Because
the mechanism by which p38 upregulates PP2A activity is uncer-
tain, and because the system dynamics depend on this mechanism,
our model implements two possibilities, each on opposite ends of
the dynamic spectrum: slow upregulation via gene transcription
of the regulatory subunit, and fast activation via phosphorylation
of the catalytic subunit.
2.1.3. ERK inhibits JNK
ERK signaling strongly induces several DUSPs, some of which
negatively regulate JNK activity. For example, DUSP4 is read-
ily induced in response to several growth factors (Legewie et al.,
2008; Cagnol and Rivard, 2012) and stabilization of DUSP16 by
ERK mediated phosphorylation at Ser-446 was observed in both
COS-7 (fibroblastic) and Hela cells (Katagiri et al., 2005). Further,
ERK enhanced JNK dephosphorylation by induction of DUSP4 in
Madin-Darby canine kidney (MDCK) epithelial cells (Paumelle
et al., 2000) and ERK inhibition in human alveolar macrophages
(which are part of the immune system in lung) reduced DUSP16
levels, resulting in increased JNK phosphorylation (Monick et al.,
2006). Together, these data indicate that the DUSP4/16 medi-
ated ERK-JNK crosstalk is conserved between cell lines (epithelial,
fibroblast, immune, and cancer cells) based on which the dynamic
model features ERK induced mRNA and protein expression of
DUSP4/16 that catalyze the dephosphorylation of JNK.
2.1.4. AKT inhibits JNK signaling
In response to several growth factors and insulin AKT mediates
survival signaling, in part, by phosphorylation and inhibition of
apoptotic proteins (Hers et al., 2011). Active AKT phosphory-
lates inhibitory sites of JNK upstream kinases at both the MAP2K
and MAP3K level (see Table 1). On the MAP3K level, phos-
phorylation of ASK1 at Ser 83 by AKT reduced JNK activity in
response to oxidative stress and serum starvation, and decreased
ASK1 dependent apoptosis in HEK 293 and L929 cells (Kim et al.,
2001). Similar results were obtained in HepG2 cells, where insulin
induced AKT activity led to phosphorylation of MLK3 at Ser 674
(Barthwal et al., 2003). On the MAP2K level, AKT phosphorylated
MKK4 at Ser 78 in response to insulin or constitutively active AKT,
which reduced JNK activity and anisomycin induced apoptosis in
HEK 293T cells (Park et al., 2002).
The dynamic model does not distinguish different MAP3Ks and
MAP2Ks in the JNK pathway, but features combined ASK/MLK
and MKK4/7 components, as MAP3Ks and MAP2Ks respectively.
We model both components taking a domain oriented approach
(Borisov et al., 2005, 2006; Kiyatkin et al., 2006; Conzelmann et al.,
2008) and assuming that the phosphorylation processes at the acti-
vation loop and the inhibitory site are independent, as described
in detail in Materials and Methods.
2.1.5. JNK inhibits ERK and p38
JNK can inhibit ERK on several levels, involving both indirect
upstream mechanisms and direct dephosphorylation upon the
transcriptional induction of DUSP expression (Junttila et al.,
2008). The model of direct ERK dephosphorylation via transcrip-
tional DUSP induction is supported by two studies showing that
the JNK-ERK crosstalk is at least partially independent of the ERK
upstream kinases MEK and Raf. First, v-Jun transcriptional activ-
ity reduced both basal and growth factor induced ERK phospho-
rylation at least partially independent of Raf (Black et al., 2002).
Second, JNK activity induced by ceramide and TNF-α blocked
growth factor stimulated ERK phosphorylation, and this inhibi-
tion required c-Jun transcriptional activity but did not involve
MEK (Shen et al., 2003).
Although the exact mechanism is poorly understood, and ele-
vated expression of DUSP1, DUSP4, and DUSP6 could not be
detected in COS-7 cells expressing active MLK3, DUSPs were sug-
gested as potential mediators of the JNK-ERK crosstalk (Shen
et al., 2003; Junttila et al., 2008). JNK can also inhibit p38, as JNK
activity inhibited both ERK and p38 signaling in mouse cardiomy-
ocytes (Peng et al., 2009) and c-Jun deficient hepatocytes showed
increased phosphorylation of p38 (Stepniak et al., 2006). The
JNKa ERK/p38 crosstalk may involve a p53-DUSP2 dependent
pathway, as the c-Jun mediated inhibition of p38 observed in hepa-
tocytes was p53 dependent (Stepniak et al., 2006) and DUSP2 was
identified as a transcriptional target of p53 in mouse embryonic
fibroblast and breast cancer cell lines (Yin et al., 2003). Further,
DUSP2 was shown to dephosphorylate ERK and p38 in NIH3T3
and HeLa cells (Chu et al., 1996) and was implicated in the inac-
tivation of ERK2 during p53 dependent apoptosis in breast and
colon cancer cell lines (Yin et al., 2003; Dickinson and Keyse, 2006).
Based on these data and neglecting p53 as possible intermediate,
the dynamic model features JNK induced expression of DUSP2
mRNA and protein and DUSP2-catalyzed dephosphorylation of
ERK and p38.
2.2. DYNAMICS OF THE CORE NETWORK
Based on the model structure in Figure 1 a dynamic model of
MAPK interactions can be derived (Kholodenko, 2006; Kholo-
denko et al., 2010). For detailed introductions to dynamic mod-
eling of cellular systems we refer to (Aldridge et al., 2006; Iglesias
and Ingalls, 2009) and, in particular with regards to ERK/MAPK
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signaling (Kholodenko, 2000; Kolch et al., 2005; Orton et al., 2005).
A successful modeling strategy keeps the model simple, yet bio-
logically relevant and capable of meaningful predictions. To that
end, the developed model contains several biologically reasonable
assumptions, simplifications, and generalizations as explained in
Materials and Methods (Sec 5). In particular, the model lumps
isoforms and kinases that share the same upstream activators and
downstream substrates into a single component wherever possible
(Figure 1, Tables 4 and 5). Crucially, the adopted simplifications
preserve the network’s feedback and crosstalk structures, reduce
the risk of over-parameterization and facilitate the mathematical
analysis of the model.
2.2.1. MAPK dynamics in response to growth factors or stress
The developed model reflects the current understanding of how
the p38 and JNK systems respond to stress (Junttila et al., 2008),
and is consistent with earlier MAPK models in the literature,
which, albeit not concerned with p38 and JNK, featured growth
factor induced ERK signaling (von Kriegsheim et al., 2009; Kholo-
denko et al., 2010; Nakakuki et al., 2010). Figure 2 presents an
overview of the system dynamics, illustrating how our model
responds to growth factor and stress signals. Generally speaking,
growth factors predominantly activate ERK and JNK, and also
AKT, albeit to different extents. The activation dynamics may be
sustained or transient, depending on type and context of the stim-
ulation (von Kriegsheim et al., 2009; Nakakuki et al., 2010). For
example, PC12 cells exhibit sustained ERK activation in response
to NGF, whereas EGF causes transient ERK dynamics due to the
activation of several negative feedback loops (Marshall, 1995; Dou-
ville and Downward, 1997; von Kriegsheim et al., 2009). These
negative feedbacks act upstream of the ERK cascade, at the level of
growth factor receptors and their adaptors, and result in a transient
input signal for the MAPK system. We can model these transient
effects taking a modular approach in which the inputs are modeled
by time-dependent functions (Nakakuki et al., 2010). Hereby, a
step input corresponds to a sustained signal, whereas a pulse input,
which drops back to the low basal level after a certain, relatively
short time period, corresponds to a transient signal. Figures 2A,B
show that in response to growth factors, the ERK dynamics quali-
tatively follow the input signal, whereas JNK responds transiently,
and only to growth factors that do not activate AKT. Stress signals
predominantly activate p38 and JNK and sometimes ERK, but to
a much weaker extent. Figure 2C shows that the JNK response to
stress is sustained for both transient and sustained stress inputs.
2.2.2. Dynamics of stress induced apoptosis in the presence of
growth factors
The core model reflects the current understanding of JNK depen-
dent apoptosis induction. In Junttila et al. (2008) a conceptual
model was proposed, in which PP2A mediated suppression of ERK
by p38 is critical for JNK mediated apoptosis. The idea is that stress
induced activation of p38 suppresses the normal ERK activity of
proliferating and differentiating cells and, subsequently, this loss
of ERK activity sensitizes the cells to JNK mediated apoptosis.
Our dynamic model is a mathematical representation of this idea
amenable to theoretical analysis. Indeed, simulating the dynamic
model with a step input of stress signals
A
B
C
D
FIGURE 2 | Dynamics of the core network in response to different
stimuli. (A) Form of input signals. Solid: sustained input, dashed: transient
input. (B–D) System responses for different stimuli. (B) Growth factor
strongly stimulating the ERK and JNK inputs, but only weakly the AKT and
p38 inputs: (C) growth factor strongly stimulating the ERK and JNK and
AKT inputs, but not the p38 input. (D) Stress signal strongly stimulating the
p38 and JNK inputs, weakly stimulating the ERK input and not stimulating
the AKT input.
uˆERK uˆp38 uˆJNK uˆAKT
(B) 1.00 0.15 1.00 0.20
(C) 1.00 0.15 1.00 0.50
(D) 0.50 1.00 1.00 0.00
where uˆ i (i =ERK, p38, JNK) denotes the maximal value of the ERK, p38,
and JNK input [see (A)].
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up38(t ) = uJNK(t ) =
{
1 for t > 0
0 otherwise
in the presence of a constant mitotic signal uERK(t )= 1 mim-
ics the data and sequence of events described in Junttila et al.
(2008). Hereby, the qualitative behavior is largely independent of
the exact mechanism of PP2A activation. For both mechanisms,
either transcriptional upregulation of PP2A or its activation by p38
induced phosphorylation, the JNK switch occurs at a 3–6 h delay
following the apoptotic stimulus (Figure 3). The delay is largely
determined by the strength of the p38-PP2A crosstalk. Decreasing
the expression rate of PP2A in the transcriptional upregulation
model or decreasing the catalytic activity of p38 toward PP2A in
the model of phosphorylation induced PP2A activation increases
the time of JNK activation (Figure 3, dashed lines). In the follow-
ing, we dissect the MAPK interaction network generating these
complex dynamics, by providing a systems level analysis of these
interactions.
2.3. ANALYZING FEEDBACK STRUCTURES
MAPK systems exhibit complex dynamic behavior, depending on
the topology of feedbacks and kinetic parameters. Although the
parameters are important for the responses observed, the network
topology in terms of feedback loops determines what qualitative
behaviors are possible (Kholodenko, 2006). Generally speaking,
negative feedback can generate (sustained) oscillations, whereas
positive feedback can generate bistability. Bistability is thought to
be important in cell fate decisions, as it is characterized by hys-
teresis and can generate irreversible switches (Novak and Tyson,
1993; Xiong and Ferrell, 2003). An example is the caspase system,
where positive feedback generates an irreversible switch between
two stable steady states; an off-state corresponding to survival and
an on-state corresponding to apoptosis (Eissing et al., 2004). As
the model features a JNK positive feedback loop, we sought to
determine under which conditions the system exhibits bistability.
2.3.1. Positive feedback and bistability of the JNK module
A convenient tool for analyzing bistability is the loop breaking
approach (Angeli et al., 2004). Loop breaking is a graphical analy-
sis tool consisting of two steps. First, break the feedback loop and
plot the input/output (i/o) relationship in steady state for the open
loop system. The resulting curve is called the steady state charac-
teristic of the open loop. Second, close the loop graphically by
plotting a straight line through the origin, whereby the slope of
the line represents the inverse strength of the feedback. For exam-
ple, unitary feedback u= y is represented by a straight line of
slope one. The intersection points of the two lines represent the
steady states of the closed loop system. In order to assess the sta-
bility of the steady states (similarly to nullclines in classical phase
plane analysis), two technical prerequisites have to be satisfied;
existence of a well-defined i/o characteristic and monotonicity,
both of which can be satisfied for simplified MAPK cascades (not
exhibiting negative feedback). For details we refer to the original
literature (Angeli et al., 2004).
A
B
C
D
FIGURE 3 |Trajectories of the core model mimic the sequence of
events (Junttila et al., 2008) that occur in response to a stress
stimulus up38(t )=uJNK(t )=1 for t >0 and the presence of a constant
mitotic signal uERK(t )=1 for all t. D2 and D4/16 denote DUSP2 and
DUSP4/16, which mediate the JNKaERK, p38, and ERKa JNK crosstalks,
respectively (see alsoTable 1). The qualitative behavior is independent of
the mechanistic details implementing p38-PP2A interaction. Two
mechanism are shown: (A,B) p38 induces PP2A gene expression,
whereby the red line in (B) represents the total level of PP2A protein (C,D)
p38 phosphorylates PP2A, whereby the red line in (D) represents
phosphorylated PP2A. (A–D) The timing of JNK activation depends on the
strength of PP2A upregulation: solid lines indicate PP2A levels comparable
to those of the other phosphatases. Dashed lines indicate reduced levels
of PP2A expression, which delays JNK activation.
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Zooming into the JNK module of the nominal model, the loop
breaking approach reveals that the JNK system is indeed bistable
for a wide range of feedback strengths (Figure 4). Note that this
result does not depend on the exact parameters, but rather the
sigmoidal input-output characteristic of the JNK cascade. In this
analysis, the feedback strength corresponds to the catalytic activ-
ity of JNK to phosphorylate ASK/MLK. More precisely, let x0, x1,
and x2 denote the concentrations of non-, single-, and double-
phosphorylated ASK/MLK, accordingly, and let further, k f be the
catalytic activity of the upstream ASK/MLK input u and kb the
catalytic activity of active JNK y, then
vphos, i = (kfuˆ + kbyˆ)xi
Kd + x0 + x1 , i = 0, 1 (1)
describes the rate of ASK/MLK phosphorylation. Hereby, a feed-
back strength of 100% corresponds to kb= kf, i.e., equal catalytic
activities of input and JNK. Figure 4 shows that for typical val-
ues of MAPK phosphorylation and dephosphorylation parameters
(Huang and Ferrell, 1996; Kholodenko, 2000; Kholodenko et al.,
2010; Nakakuki et al., 2010) the strength of the positive feedback
can be reduced to less than 40% before bistability is lost.
The point of transition from monostable to bistable behavior
is called pitchfork bifurcation and depends not only on the feed-
back strength, but also the upstream input. Recall that ASK/MLK
are not only phosphorylated by JNK feedback, but also upstream
inputs (such as GTPase recruited kinases or MAP4Ks). For the
graphical analysis, assuming a constant input corresponds to a
rightshift of the feedback line, whereby the value of the rightshift
indicates the strength of the input (Figure 4). Applying a feedfor-
ward input to a feedback system that was originally not bistable
(due to a low feedback gain), can push it into a bistable regime and
beyond. Hereby the system moves from a monostable-off regime
through a bistable regime to a monostable-on regime (Figure 4).
Further, a combined analysis of feedback and feedforward input
shows that even for appropriate inputs, bistability is lost if the
feedback strength is too low. In fact, in order for a bistable regime
to exist, the inverse of the feedback strength has to be smaller than
the maximal slope of the sigmoidal i/o characteristic (Figure 4).
2.3.2. Negative feedback via dual specificity kinases
The core model depicted in Figure 1 does not contain negative
feedback within the JNK module. However, negative feedback is
not uncommon in MAPK cascades and is often context depen-
dent. For instance, ERK possesses several negative feedback loops
that are activated in a stimulation dependent manner in response
to EGF, but not NGF or HRG (Santos et al., 2007; von Kriegsheim
et al., 2009; Nakakuki et al., 2010). With regard to JNK signal-
ing, several DUSPs exhibit catalytic activity toward JNK and may
be induced by active JNK (Dickinson and Keyse, 2006; Boutros
et al., 2008). One such example is DUSP1 (Bokemeyer et al., 1996).
Therefore, we explored the possibility of DUSP1 mediated nega-
tive feedback in the JNK module. Note that the system is not
monotonic because of the negative feedback. Consequently,graph-
ical analysis using loop breaking cannot assess the stability of the
steady states but only their existence and should be complemented
by local stability analysis or simulations.
A
B
C D
FIGURE 4 | Analysis of JNK positive feedback using the loop
breaking approach. Here, g denotes the feedback strength, i.e., the
ratio g = k b/k f in (1). (A–D) Solid, blue lines represent the steady state
characteristic of i/o-system. Dashed lines indicate different feedback
configurations, whereby the slope represents the feedback strength and
the rightshift measured from the origin the feedforward stimulus. (A)
Illustration of the loop breaking approach (for a detailed explanation see
main text). (B) Depending on the feedback strength, the JNK system
exhibits monostable or bistable behavior (u=0). (C) Simultaneous
feedback and feedforward stimulation can push the system from a
monostable-off (white), through a bistable (light green), to a
monostable-on (light red) regime. (D) No bistable behavior is possible for
feedback gains lower than the inverse of the maximal slope of the i/o
characteristic.
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Negative feedback to upstream components of JNK can
decrease ultrasensitivity and lead to oscillations (data not shown,
see for example Kholodenko et al., 2010 for a general treat-
ment). In contrast, DUSP1 mediated, slow negative feedback
can disable the bistable switch generated by the fast positive
feedback loop (Figure 5). Depending on the relative feed-
back strength, a transiently bistable regime exists, in which
the JNK system responds with prolonged activity in response
to a short lived stimulus. Hereby, the positive feedback main-
tains the on-state after the input subsides, but only until the
slow negative feedback takes effect, diminishing the (initial) i/o
characteristic of the system, at which point JNK switches off
(Figure 5).
2.4. REGULATION OF THE JNK APOPTOTIC SWITCH BY CROSSTALK
Mitogenic and survival signals regulate the JNK apoptotic switch
through crosstalk occurring on several levels (Figure 1). We can
distinguish two mechanisms; firstly, inhibition of JNK activation
by phosphorylation of upstream JNK kinases at inhibitory residues
and secondly enhanced JNK dephosphorylation by upregulation
of phosphatases. The first mechanism is mediated by AKT, a
classical mediator of survival signaling. The second mechanism,
is mediated via ERK, a classical mediator of proliferative and
differentiation signaling.
In the following, we use the nominal model to decipher how
MAPK crosstalk integrates different mitotic, survival, and stress
signals, particularly focusing on the bistable switch. First, we
stimulate the model with constant mitotic and survival inputs
uERK(t ) = uˆERK, uAKT(t ) = uˆAKT and let the trajectories relax
to steady state. Then we apply stress stimuli in the form of step
inputs
up38(t ) =
{
0 for t < 0
uˆp38 otherwise,
uJNK(t ) =
{
0 for t < 0
uˆJNK otherwise.
It is useful to define the switching threshold as the value of uˆJNK
at which JNK switches from the off to the on-state.
2.4.1. How AKT controls the JNK switch
AKT signaling affects the switching threshold and regulates the
JNK on-state (Figure 6). Increasing AKT activity decreases the
value of the JNK on-state. Whereas bistable behavior is still pos-
sible for moderate AKT signaling, strong AKT signaling abrogates
the JNK apoptotic switch and permits only moderate, proliferative
JNK activity.
The regulation of the JNK switch by AKT does not depend
on the exact topology of the crosstalk, as isolated crosstalk at the
MAP2K or the MAP3K levels exhibits similar control patterns
(Figure 6). One slight difference is that crosstalk on the MAP3K
level has slightly more impact on the switching threshold and
admits some sensitivity of the proliferative regime with respect
to the JNK input, meaning that changing the JNK input changes
the level of JNK activity (orange and red curves in Figure 6B).
In contrast, the curves resulting from the MAP2K crosstalk are
almost flat, meaning that changing the JNK input does not affect
JNK activity other than switching it on or off (Figure 6C). Thus,
the MAP2K crosstalk model quickly saturates for all levels of AKT
activity, after which changing the input has no effect on the output.
A
B C
D
E
FIGURE 5 | Modulation of the bistable switch by negative feedback. (A)
Scheme of the extended JNK model, in which active JNK induces the
expression of DUSP1 mRNA (mD) and protein (pD). (B) Loop breaking
analysis showing a transient bistable regime (light green). Blue: initial i/o
characteristic of the open loop system at t = 30 min, before the negative
feedback takes effect. Red: steady state i/o characteristic. (C–E) Trajectories
of the JNK response after stimulation with a transient pulse of 3 min (u(t )=1
for 0< t <3) for different feedback strengths: (C) g =0, (D) g =0.7, (E)
g =1.5. Dashed lines indicate the responses without negative feedback, solid
lines with negative feedback.
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A
B
C
FIGURE 6 | Regulation of switch by AKT negative crosstalk. (A–C)
Interaction schemes and simulated dose responses for crosstalk at different
levels: MAP3K and MAP2K level (A); MAP3K level (B); and MAP2K level (C),
whereby active AKT phosphorylates and inhibits ASK/MLK and/or MKK4/7 as
indicated. Left: interaction scheme. Right: dose responses with respect to the
JNK input uJNK for different AKT activation levels; uJNK(t) = uˆJNK for t > 0;
uAKT = uˆAKT for all t ; blue curves indicate low, red lines high AKT activity;
dashed lines indicate a switch from low to high JNK activity.
In contrast, the MAP3K crosstalk model does not saturate when
AKT activity is high, and after crossing a certain threshold, JNK
responds linearly to changes in the input.
2.4.2. How ERK and p38 control the JNK switch
Increasing the input of ERK signaling shifts the switching thresh-
old toward higher JNK inputs, but has little effect on the value
of the on-state (Figure 7). Crucially, no intermediate JNK activa-
tion is possible, JNK is either off or on, Further, the strength of
apoptotic JNK signaling once activated, is independent of the ERK
input.
The regulation of the JNK switch by ERK depends on the p38-
ERK crosstalk, p38→PP2Aa ERK. Normal, non-transformed
cells can initiate the JNK apoptotic switch depending on the level of
PP2A expression and p38 signaling. Here, increasing p38 pathway
activation and PP2A expression increases the regime of tolerable
ERK stimuli for which JNK inputs can initiate the apoptotic switch
(Figure 7B). In contrast, in transformed and tumorigenic cells,
lacking p38-ERK crosstalk, even very moderate stimulation of the
ERK pathway prevents the JNK apoptotic switch (Figure 7C).
2.4.3. How different DUSP mediated crosstalk patterns shape JNK
dynamics
DUSPs are important regulators of MAPK activities. The main
function of DUSPs is to dephosphorylate the activation loop of
MAPKs, often with overlapping substrate specificity (Dickinson
and Keyse, 2006; Boutros et al., 2008; Bermudez et al., 2010).
Importantly, several DUSPs are in turn regulated by MAPKs
and induced in response to mitotic, differentiation, and stress
signals. Therefore, the regulation of DUSPs can occur on sev-
eral levels including the regulation of DUSP phosphatase activity,
substrate specificity, protein stability, and gene expression (Dick-
inson and Keyse, 2006; Boutros et al., 2008). The resulting feed-
back and crosstalk structures are complex, and lack a complete
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A
B
C
FIGURE 7 | Regulation of the JNK switch by ERK and p38. (A)
Interaction scheme. (B,C) Simulated dose responses with respect to the
JNK inputs for different levels of constant ERK pathway stimulation;
uJNK(t) = uˆJNK for t > 0; up38(t )=1 for t >0; uERK = uˆERK for all t ; blue curves
indicate low, red lines high ERK stimulation; dashed lines indicate a switch
from low to high JNK activity. (B) Dose responses for
primary/non-transformed cells exhibiting p38aERK crosstalk. (C) Dose
responses for transformed/tumorigenic cells lacking the p38aERK
crosstalk (no PP2A upregulation in the model).
understanding. Owing to this complexity, we formulated several
models based on reported DUSP specificities in the literature
(Table 3; Dickinson and Keyse, 2006; Boutros et al., 2008; Patter-
son et al., 2009). By focusing on MAPK induced gene transcription
and neglecting the complexity of posttranscriptional DUSP reg-
ulations, these models are used to analyze the effects of different
crosstalk structures.
DUSP1 expression can be induced by active p38 and JNK
depending on the cell context (Table 3), and it is often upreg-
ulated in cancer. The JNK induced DUSP1 expression and the
resulting negative feedback onto JNK was already analyzed in Sec.
2.3.2, Figure 5. In this section we focus on the p38 induced DUSP1
expression and resulting p38a p38/JNK crosstalk. We have already
seen in Sec. 2.4.2, Figure 7 that p38a ERKa JNK crosstalk is a
critical regulator of the JNK switch. However, the core model also
features JNKa ERK/p38 crosstalk mediated by DUSP2 expression,
and we ask whether this crosstalk is also crucial for the JNK switch
by deleting DUSP2 in the model.
Figure 8 shows the responses for c patterns to step inputs of
stress signals,
up38(t ) = uJNK(t ) =
{
1 for t > 0
0 otherwise
in the presence of a constant mitotic signal uERK(t )= 1 for all t. We
can distinguish two qualitatively different behaviors, irrespective
of the presence or absence of ERK feedback (mediated by DUSP4
or DUSP5/6). The models in the first group do not feature p38
induced DUSP1 expression, and DUSP2 deletion in these models
has little effect on the JNK activation dynamics and the JNK switch
(Figures 8A,B). Within this group, model A is the core model,
but model B also includes DUSP4 mediated negative feedback
to ERK; ERKa ERK/JNK (Table 3), resulting in accelerated JNK
activation dynamics (Figure 8B). In contrast, the models in the
second group feature p38 induced DUSP1 expression, and dele-
tion of DUSP2 in these models abrogates the JNK switch, resulting
in reduced, moderate JNK activity (Figures 8C–E). In addition to
the core interactions, model C includes this p38 induced DUSP1
expression, which slightly delays the JNK activation dynamics, but
does not obliterate the JNK switch (Figure 8C). However, deleting
DUSP2 in model C abrogates the JNK switch and results in only
moderate JNK activity (Figure 8C). Summarizing, these mod-
els predict that abrogation of JNK dependent apoptosis requires
both p38 induced expression of DUSP1 and downregulation or
deletion of DUSP2. Adding ERK negative feedback mediated by
DUSP4 (model D) or DUSP4 and DUSP5/6 (model E) to model
C does not alter the JNK dynamics or the behavior of the DUSP2
deletion (Figures 8D,E).
The robustness of the core model with respect to either (i) gain
of p38 induced DUSP1 or (ii) loss of JNK induced DUSP2 in iso-
lation, can be explained as follows. To lock JNK into the highly
active state (in the presence of ERK input), ERK activity needs to
be suppressed, either by p38 activity via the PP2A-ERK link or by
JNK activity via the DUSP2-ERK link. In the absence of DUSP1,
p38 activity is sufficiently high to suppress ERK. In presence of
DUSP1, the p38 activity is reduced, and ERK is not sufficiently sup-
pressed by p38-PP2A alone. Here, the JNK-DUSP2-ERK crosstalk
becomes crucial as it complements the p38-PP2A mediated ERK
inhibition, which explains the fragility of the JNK switch if both
elevation of p38 induced DUSP1 and loss of JNK induced DUSP2
occur simultaneously.
3. DISCUSSION
The process of building a multi-pathway model is quite complex,
as are the implications of its analysis for cell biology and cancer.
Both are discussed in the following.
3.1. THEORETICAL CONSIDERATIONS
The network depicted in Figure 1 synthesizes information from
different cell types in the literature. However, a complete pic-
ture of MAPK crosstalk is still lacking. The network of DUSP
interactions is particularly difficult to dissect, as DUSPs can be
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Table 3 | Inducible DUSPs implemented in the model.
DUSP Induced by Substrates comments/references
DUSP4/16 ERK (JNK) JNK, ERK Oncogenic Ras activity induces DUSP4 mRNA and protein synthesis and stabilizes DUSP4 protein
(Cagnol and Rivard, 2012); ERK phosphorylation stabilizes DUSP16 protein, which dephosphorylate
JNK ( p38>ERK, mRNA expression was not analyzed (Katagiri et al., 2005)
DUSP2 JNK (ERK) ERK, p38 JNK/c-Jun activity and transformed v-JUN enhances ERK dephosphorylation (Black et al., 2002; Shen
et al., 2003); DUSP2 was implicated in regulating the JNK ( ERK/p38 crosstalk (Jeffrey et al., 2006);
DUSP2 dephosphorylates ERK and p38 (Dickinson and Keyse, 2006)
DUSP1 p38 (ERK, JNK) p38, JNK p38 induces DUSP1, which dephosphorylates p38 and JNK (Hu et al., 2007; Small et al., 2007); DUSP1
mRNA is induced by p38 in response to heat shock (marcophages; Wong et al., 2005), anisomycin (VSMC;
Bokemeyer et al., 1998), arsenite, UVC (C3H 10T1/2; Li et al., 2001); and by ERK in response to serum
(CCL-39; Brondello et al., 1997), PDGF, phorbol ester, angiotensin II (VSMC; Bokemeyer et al., 1998), heat
shock, H2O2 (C3H 10T1/2; Li et al., 2001); and by JNK after stress (NIH 3T3; Bokemeyer et al., 1996)
DUSP5/6 ERK ERK MEK/ERK but not PI3K/AKT or p38/JNK regulates DUSP6 mRNA (stabilization) and protein
(destabilization) levels (Bermudez et al., 2011) Ras and ERK activity induces dusp5 mRNA and regulates
DUSP5 protein stability (Kucharska et al., 2009; Cagnol and Rivard, 2012)
Bold face indicate activities used in the nominal model. Normal face indicate activities used in Sec. 2.4.3. Round brackets indicate activities not used in this study
but implemented in the model, wherewith the model is readily adaptable to cell type and cancer specific interaction patterns by setting the parameters in the model
accordingly (see alsoTable 5).
induced by several MAPKs and, in turn, can act on several sub-
strates (Boutros et al., 2008). Importantly, Figure 1 is not an
overview summarizing all possible interactions, but depicts a core
model of MAPK interactions that are essential for implementing
the JNK proliferative-apoptotic switch. From a systems-theoretical
perspective, the crucial determinant of the model’s behavior is that
these crosstalks and feedbacks exists, not which molecules mediate
it. Therefore, although all interactions in the model are strongly
supported by experimental evidence in the literature, the particu-
lar DUSP isoforms involved may differ depending on cell type and
context. The DUSP2 connection in our model is based on data
from fibroblast and cancer cell lines (see Sec. 2.1.5), but is partic-
ularly uncertain. DUSP2 specifically dephosphorylated ERK and
p38 in NIH3T3 and HeLa cells (Chu et al., 1996), but targeted JNK
in macrophages and mast cells (Jeffrey et al., 2006). These differ-
ences suggest that the JNKa ERK/p38 crosstalk may be mediated
differently in immune cells compared to fibroblasts and epithe-
lial cancer cells. In concordance with our model, macrophages,
and mast cells exhibited JNKa ERK/p38 crosstalk, but unlike our
model this crosstalk was not mediated by DUSP2, as DUSP2 dele-
tion in macrophages and mast cells increased JNK activity and
decreased ERK and p38 phosphorylation (Jeffrey et al., 2006).
These cell type specific differences highlight the importance of
flexible modeling approaches that facilitate the analysis of different
model configurations. As illustrated in Section 2.4.3, testing alter-
native model topologies can readily be done by setting parameters
in the current model.
3.1.1. Modularity and neglected components
The nominal model neglects several context dependent MAPK
crosstalks and feedbacks that are not necessary for implement-
ing the JNK apoptotic switch. For example, ERK features several
(negative) feedback loops (Birtwistle et al., 2007; von Kriegsheim
et al., 2009). Generally, this feedback acts upstream of MEK (on
the components that are not included in the model, such as growth
factor receptors, their adaptors and GTPases), thereby transiently
shaping Raf activation, i.e., the input of the model u1. Thus,
although the model does not account for ERK feedbacks explicitly,
it can account for different Raf activation patterns by choosing u1
accordingly as a time-dependent input function (Nakakuki et al.,
2010). One advantage of this modular approach is that it facilitates
further model development as the input functions can be replaced
by additional sets of differential equations. Therewith, the model
can be easily connected to other models describing the dynamics
of different receptors and GTPases.
Future model development will concern including more mech-
anistic detail, in particular with regard to the well-studied ERK
cascade. For instance, ERK exhibits a strong negative feedback to
Raf-1 in response to EGF which alters the efficiency of MEK inhi-
bition (Sturm et al., 2010) and might affect the p38-PP2A-MEK
crosstalk. In contrast, IGF predominantly activates ERK via B-
Raf without featuring negative feedback (Fritsche-Guenther et al.,
2011), illustrating that these model extensions will be context and
stimulus dependent.
3.1.2. Spatial aspects
Mathematically, the model describes the cell as well mixed com-
partment and does not distinguish subcellular compartments.
This simplification might not be an issue for the ERK-JNK
crosstalk as it features both a nuclear (DUSP4) and a cytosolic
(DUSP16) component, but might overestimate the effects of the
JNK-ERK/p38 and p38-JNK crosstalks, because their mediators
DUSP2 and DUSP1 are exclusively localized in the nucleus. In
general, the spatial regulation of DUSPs and MAPKs is complex,
as DUSPs can both shuttle and sequester MAPKs in the nucleus
and cytosol (Masuda et al., 2001; Karlsson et al., 2004; Mandl et al.,
2005; Caunt and Keyse, 2012). In addition, many MAPKs and
their MAP2Ks also shuttle between the cytosol and nucleus, and
activation and deactivation can take place in both compartments
(Plotnikov et al., 2011). For instance, MKK3/6 are located both
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A
B
D
C
E
FIGURE 8 | Dynamics of the apoptotic switch for different crosstalk
patterns. Center and right columns show the trajectories of MAPKs
activation after a stress stimulus (up38 =uJNK =1 for t >0) in the
presence of a mitotic signal (uERK =1 for all t ) for the indicated
interaction patterns. Top left: scheme of MAPK interactions. Black arcs
indicate core interactions, green arcs indicate additional DUSP
mediated interactions analyzed in panels (A–E). Top right: table
summarizing the different DUSP interaction patterns corresponding to
(A–E). (A) Core model (see Figure 1 for a detailed scheme). (B) Core
model and DUSP4 mediated negative feedback on ERK. (C) Core
model and p38 induced DUSP1 expression mediating negative
feedback to ERK and crosstalk to JNK: p38 ( p38/JNK. (D) Model C and
DUSP4 mediated negative feedback on ERK. (E) Model D and DUSP5/6
mediated negative feedback on ERK.
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Table 5 | Reactions, rate expressions and parameters of the phosphatase expression processes in the core model.
Reaction Forward rate law Reverse rate law K (unitless) k synt (min−1) kdeg (min−1) α β γ
(unitless)
∅ p38,JNK
 dusp1 ksynt (αp38+βJNK)
2
K 2+(αp38+βJNK)2 kdegdusp1 0.5 0.0231 0.0231 1 0 0
∅ dusp1
 DUSP1 ksyntdusp1 kdegDUSP1 – 0.231 0.0231 – – –
∅ ERK,JNK
 dusp2 ksynt (αERK+βJNK)
2
K 2d +(αERK+βJNK)2
kdegdusp2 0.5 0.0231 0.0231 0 1 0
∅ dusp2
 DUSP2 ksyntdusp1 kdegDUSP1 – 0.231 0.0231 – – –
∅ ERK,JNK
 dusp4/16 ksynt (αERK+βJNK)
2
K 2d +(αERK+βJNK)2
kdegdusp4/16 0.5 0.0231 0.0231 1 0 0
∅ dusp4/16
 DUSP4/16 ksyntdusp4/16 kdegDUSP4/16 – 0.231 0.0231 – – –
∅ ERK
 dusp5/6 ksynt (αERK)2K 2d +(αERK)2 kdegdusp5/6 0.5 0.0231 0.0231 0 – 0
∅ dusp5/6
 DUSP5/6 ksyntdusp5/6 kdegDUSP5/6 – 0.231 0.0231 – – –
∅ p38
∗∗

 pp2a ksynt (αp38)
2
K 2d +(αp38)2
kdegpp2a 0.5 0.0231 0.0231 0 – 0
∅ pp2a
 PP2A ksyntpp2a kdegPP2A – 0.231 0.0231 – – –
The parameters α, β, and γ are structural parameters ∈{0, 1} that determine which MAPK induces which phosphatase. The values given in the table relate to the core
model.
in the cytosol and nucleus and can mediate p38 activation in the
nucleus (Ben-Levy et al., 1998). Both ERK and MEK constitutively
shuttle between the cytosol and nucleus, and ERK can be activated
in both compartments (Fujioka et al., 2006). Likewise, ERK deac-
tivation by DUSPs can occur in the nucleus and cytosol depending
on the localization of particular DUSP isoforms. Nuclear DUSPs
seem to serve as anchoring proteins that retain dephosphorylated
ERK in the nucleus to prevent re-activation in the cytosol (Lenor-
mand et al., 1998). Thus, spatial context seems to play an intricate
role in modulation of MAPK activities, more work would will be
needed to decipher and model the spatial regulations of DUSPs
and their effects on MAPK activities.
3.1.3. Parameter dependency
The parameterization of dynamic models is complex, usually
requiring time-course measurements in several different condi-
tions and fitting of the model using global optimization algo-
rithms, whereby the resulting parameter estimates might vary
depending on cell type and experimental context. To obtain a
nominal model, we chose the parameters values in concordance
with earlier models of MAPK signaling and kinetic information
in the literature, such as half life measurements of DUSPs (see
Materials and Methods). For simplification, the model assumed
equal parameters for different MAPKs. We do not expect this
assumption to withstand experimental validation during para-
meter estimation as it was adopted for theoretical reasons. (We
refer to von Kriegsheim et al., 2009; Cirit et al., 2010; Nakakuki
et al., 2010 for compilations of kinetic parameters and Legewie
et al., 2008 for turnover rates.) First, assuming equal binding
constants for kinases acting on shared substrates established sym-
metries in the model that yielded simplified, Michaelis-Menten-
like kinetic expressions in a model reduction step (see Materi-
als and Methods). Second, choosing equal catalytic activities for
the different MAPKs simplifies analyzing the model based on
the rationale that, in this case, the system dynamics are domi-
nated by the systems structure and not biased toward possible
imbalances of particular parameter values. Nonetheless, an impor-
tant feature of the model is that the bistable nature of the JNK
apoptotic switch does not depend on the exact parameter val-
ues used, but relies on feedback structure and sigmoidal shape of
the i/o characteristic. Nevertheless, in order to achieve a quan-
titatively predictive model, future work would be needed for
data collection and parameterization, particularly with regard
to stress activated kinases where little kinetic information is
available.
3.2. BIOLOGICAL IMPLICATIONS
Although the idea of a JNK positive feedback loop is not new (Ven-
tura et al., 2006), a detailed understanding of how JNK feedback
structures and crosstalk regulate cell fate is still missing (Wagner
and Nebreda, 2009). Earlier modeling studies considered MAPK
systems in isolation from each other, either focusing on ERK sig-
naling and its feedbacks (von Kriegsheim et al., 2009; Kholodenko
et al., 2010; Nakakuki et al., 2010; Sturm et al., 2010), or p38-
JNK crosstalk (Sundaramurthy et al., 2009; Sundaramurthy and
Gakkhar, 2010). In contrast, this manuscript provides a systems
level model of JNK positive feedback, its regulation by pathway
crosstalk including ERK and AKT signaling, and a mathemati-
cal analysis of how this system integrates different proliferative,
survival, and proapoptotic stimuli, thereby determining cell fates.
The model helps us to understand the experimental observations
in the literature, and incorporates several ideas. First, the magni-
tude and temporal profile of JNK signaling is important, as the
anti-apoptotic, proliferative response is associated with moderate,
but rapid JNK activation, whereas the proapoptotic response is
associated with later, more sustained JNK activation (Lamb et al.,
2003; Sakon et al., 2003; Ventura et al., 2006). Second, both mitotic
signaling via ERK and survival signaling via AKT modulate the
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JNK apoptotic switch (Molton et al., 2003; Junttila et al., 2008).
Third, the loss of negative crosstalk from p38 to ERK dysregulates
JNK dependent apoptosis, which is crucial for cell transformation
(Arroyo and Hahn, 2005; Junttila et al., 2008). Overall, JNK sig-
naling involving a positive feedback loop takes a center stage in
the proposed model, which explains how ERK and AKT mediated
crosstalk modulates and switches proliferative and proapoptotic
JNK signaling.
3.2.1. Differences of ERK and AKT control over the JNK apoptotic
switch
In the model, the switch to apoptotic JNK signaling depends cru-
cially on a JNK positive feedback loop, which, once activated,
causes high levels of sustained JNK activity. This switch is mod-
ulated by ERK and AKT signaling in different ways. ERK activity
shifts the threshold for the JNK apoptotic switch to higher val-
ues, but has no effect on the strength of apoptotic JNK signaling.
The mechanism underlying this behavior is the enhanced dephos-
phorylation of JNK, whereby JNK activity is either sufficient to
activate the JNK positive feedback loop and inhibit ERK signaling,
or does not reach this threshold level. In contrast, AKT activity
predominantly regulates the strength of JNK signaling by reduc-
ing the value of the JNK on-state with little effect on the switching
threshold. The mechanism behind this is the phosphorylation and
inhibition of JNK upstream kinases, which reduces the strength
of both, the feedforward loop and the feedback loop. Crucially,
the reduced feedback strength yields a reduced level of the JNK
on-state.
3.2.2. Transformed versus normal cells
Transformed cell differ from normal cells in that they lack PP2A
mediated negative crosstalk from p38 to ERK (Junttila et al., 2008).
In the model, the loss of p38-ERK negative crosstalk severely
increases the JNK switching threshold, thus desensitizing the cells
from stress induced apoptosis. Taken together, these observations
suggest the involvement of the JNK apoptotic switch in cellu-
lar senescence as follows. With each cell cycle, cells accumulate
DNA damage and experience a shortening of the chromosomal
telomeres. Once a certain threshold of DNA damage or telomere
shortening is crossed, senescence occurs, or apoptosis is induced.
The loss of p38-ERK crosstalk would increase this threshold to
unphysiological levels, thus rendering transformed cells biologi-
cally immortal. In this senescence model, AKT is not involved, as
the AKT-JNK crosstalk does not alter the apoptotic threshold, but,
instead, prevents the apoptotic switch in the presence of survival
signals.
4. CONCLUSIONS
The developed model explains how pathway crosstalk harmonizes
MAPK responses resulting in pivotal cell fate decisions that differ
markedly between transformed and non-transformed cells. In the
proposed model, JNK can switch from a transient to sustained
activity due to multiple positive feedback loops. Once activated,
positive feedback locks JNK into a highly active state that pro-
motes cell death. The switch is differentially regulated by the ERK,
p38, and AKT pathways. ERK activation enhances the dual spec-
ify phosphatase (DUSP) mediated dephosphorylation of JNK and
shifts the threshold of the apoptotic switch to higher inputs. In
non-transformed cells, activation of p38 can restore the thresh-
old by inhibiting ERK activity via the phosphatases PP1 or PP2A.
Finally, AKT activation inhibits the JNK positive feedback, thus
abrogating the apoptotic switch and allowing only proliferative
signaling. The model is most valuable for understanding how can-
cerous deregulations disturb the signal processing of internal and
external cues and provides possible explanations for certain drug
resistances. For instance, oncogene induced ERK hyperactivity
prevents the normal apoptotic switch and provides possible expla-
nations for the complex and tumor specific behavior of MAPK
systems (Dickinson and Keyse, 2006; Wagner and Nebreda, 2009;
Bermudez et al., 2010).
In regards to interactions necessary for facilitating the switch
between transient and sustained JNK activity, our model predicts
a critical role for DUSP1 and DUSP2 expression patterns. In the
model, both expression of DUSP1 and deletion of DUSP2 are
necessary for preventing the JNK apoptotic switch (as the nomi-
nal model is robust to dysregulation of either DUSP in isolation).
The result is particularly interesting in the context of (a) cancer, as
many cancers show increased expression of DUSP1 and reduced
expression of DUSP2, and (b) tumor related conditions such as
hypoxia, where low oxygen levels upregulate DUSP1 and down-
regulate DUSP2 (Patterson et al., 2009; Lin et al., 2011). According
to our model, these conditions would prevent the JNK apoptotic
switch. Indeed, forced expression of DUSP2 abolished hypoxia
induced chemoresistance in human cancer cell lines (Lin et al.,
2011), and inhibition of DUSP1 sensitized several resistant can-
cer cell lines to JNK dependent apoptosis (Laderoute et al., 1999;
Sánchez-Pérez et al., 2000; Small et al., 2007; Wang et al., 2008).
The current model represents a core network of MAPK inter-
actions critical for the switch from proliferative to apoptotic sig-
naling. The model is canonical in the sense that it generalizes
and integrates information from different cell lines by focusing on
interactions that are (a) readily observed in several cell lines and (b)
important for controlling the JNK bistable switch. The canonical
model forms a basis for experimental design and can be tailored to
different experimental systems on two levels by (a) parameter esti-
mation (the epigenetic and disease background of particular cell
types is reflected in different parameter values of the model) and
(b) extending the model to incorporate different MAPK isoforms,
upstream and downstream signaling and scaffolds. Such refined
and validated models possess quantitative predictive power and
cannot only be used for identifying gaps in knowledge by test-
ing the model predictions, but also for predicting the effect of
drugs, thus building the theoretical basis for identifying optimal
treatment strategies.
5. MATERIALS AND METHODS
This section describes how the different components depicted in
Figure 1 are modeled mathematically.
5.1. MODEL OF KINASE ACTIVATION
Activation of mitogen-activated protein kinases requires the phos-
phorylation of two conserved amino acid residues, whereby several
upstream kinases can act as enzymes facilitating the phosphoryla-
tion. Consider the reaction scheme in Figure 9, where we assumed
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A B
FIGURE 9 | Schemes of a double phosphorylation cycle with two
kinases. X denotes the protein to be phosphorylated with the index
indicating its phosphorylation status. U denote the kinases catalyzing the
phosphorylations. (A) Full mechanistic scheme modeled using mass action
kinetics. For clarity of presentation, the dephosphorylation reactions are not
depicted. (B) Reduced scheme modeled using Michaleis-Menten type
kinetics as derived in the main text; k 1 and k 2 denote the catalytic activity
of U1 and U2, respectively. P denotes the phosphatase catalyzing the
dephosphorylation.
that only one enzyme can be bound to the kinase at any one time.
Using the law of mass action the reaction rates are described by
r1 = p1x0u1 − p−1x0u1, (2a)
v1 = k1x0u1, (2b)
r2 = p1x1u1 − p−1x1u1, (2c)
v2 = k1x1u1, (2d)
r3 = p2x0u2 − p−2x0u2, (2e)
v3 = k2x0u2, (2f)
r4 = p2x1u1 − p−2x1u2, (2g)
v4 = k2x1u2, (2h)
and the dynamics of the system are governed by the ordinary
differential equations
dx0
dt
= −r1 − r3, (3a)
dx1
dt
= v1 − r2 + v3 − r4, (3b)
dx2
dt
= v2 + v4, (3c)
dx0u1
dt
= r1 − v1, (3d)
dx1u1
dt
= r2 − v2, (3e)
dx0u2
dt
= r3 − v3, (3f)
dx1u2
dt
= r4 − v4. (3g)
We can obtain a simplified description of this system resem-
bling classical Michaelis Menten kinetics using the conserved
moieties for the enzymes
ui = uˆi −x0ui − x1ui , (i = 1, 2),
where uˆi denotes the total concentration of enzyme i, and assum-
ing rapid equilibrium for the binding reactions by solving the
system ri= 0 (i= 1, . . ., 4) for the complexed states x0u1,x1u1,x0u2,
x1u2. Substituting the solution into the phosphorylation reactions
vi (i= 1, . . ., 4) yields
v1 = uˆ1 k1x0
Kd1 + x0 + x1 , (4a)
v2 = uˆ1 k1x1
Kd1 + x0 + x1 , (4b)
v3 = uˆ2 k2x0
Kd2 + x0 + x1 , (4c)
v4 = uˆ2 k2x1
Kd2 + x0 + x1 , (4d)
with Kdi= p−i /pi (i= 1, 2) denoting the dissociation constant of
the enzyme-kinase complexes. We can further simplify the model
by assuming equal dissociation constants Kdi=Kd, wherewith
vphos1 = v1 + v3 = (k1 uˆ1+k2 uˆ2)x0
Kd + x0 + x1 , (5a)
vphos2 = v2 + v4 = (k1 uˆ1+k2 uˆ2)x1
Kd + x0 + x1 . (5b)
Assuming equal dissociation constants is a strong assump-
tion, in particular for different enzymes, but reduces the risk of
over-parameterization and facilitates the theoretical analysis of
the model.
Dephosphorylation of kinases is catalyzed by phosphatases
and a mathematical model can be derived analogously, result-
ing in kinetic expressions resembling equation (5). Therewith, a
complete model of a double phosphorylation cycle is given by
d
dt
x0 = −
∑
i
(ki uˆi)
x0
Kd + x0 + x1
+
∑
j
(k−j vˆ j)
x1
K−d + x1 + x2 ,
d
dt
x2 =
∑
i
(ki uˆi)
x1
Kd + x0 + x1
−
∑
j
(k−j vˆ j)
x2
K−d + x1 + x2 ,
where ui denote the concentrations of the upstream kinases, vj the
concentrations of the phosphatases.
5.2. MODEL OF KINASE INHIBITION BY PHOSPHORYLATION
Some kinases can be rendered catalytically inactive by phospho-
rylation at inhibitory sites. Examples are ASK1 and MKK4, which
can be phosphorylated by AKT at Ser 83 and Ser 78, respectively
(Kim et al., 2001; Park et al., 2002). There is little, mostly con-
flicting information available on whether phosphorylation of the
inhibitory site depends on the phosphorylation status of the acti-
vating sites, or, in turn, whether phosphorylation at the inhibitory
site affects the phosphorylation/dephosphorylation of the activat-
ing sites. Hence, we take a domain oriented approach accounting
for all possible combinations of the phosphorylation status (but
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neglecting the possibility of a trimeric complex), resulting in a
model comprising six distinct states (Borisov et al., 2005, 2006;
Kiyatkin et al., 2006; Conzelmann et al., 2008).
Assume that the phosphorylation status of the activating site
does not affect the binding of the inhibitor enzyme and the
phosphorylation of the inhibitory site, and vice versa that the
phosphorylation status of the inhibitory site does not affect the
binding of the activating enzyme and the phosphorylation of the
activating site. Assume further, that only one enzyme can be bound
to the kinase at any one time, i.e., a trimeric complex consisting of
activating enzyme, kinase, and inhibitory enzyme is not possible.
Then the reaction scheme in Figure 9 can be extended to account
for kinase inhibition:
Xi
UI
XiI , (i = 0, 1, 2),
where XiI denotes the kinase phosphorylated at the inhibitory site
and Ui the enzyme catalyzing this phosphorylation.
Similarly to equation (5) a mathematical description can be
derived, yielding reaction kinetics for (de-)phosphorylation at the
activating sites of the form
rphos =
∑
l kl uˆl y
Kd + x0 + x1 + x0I + x1I ,
rdephos =
∑
l k−l vˆ−l z
K−d + x1 + x2 + x1I + x2I ,
where (y, z)∈ {(x0, x1), (x1, x2), (x0I , x1I ), (x0I , x1I )} and reac-
tion kinetics for (de-)phosphorylation of the inhibitory site of the
form
rphos,I = kI uˆI y
KI + x0 + x1 + x2 ,
rdephos,I = k−I vˆ I z
K−I + x0I + x1I + x2I ,
where (y, z)∈ {(x0, x0I ), (x1, x1I ), (x2, x2I )}.
5.3. MODEL OF PHOSPHATASE EXPRESSION
The expression levels of inducible phosphatases depend on sev-
eral parameters, including the activities of upstream MAPKs
(Figure 1). We model the rate of mRNA synthesis using sigmoidal
Hill functions of activator kinase concentrations (motivated by
thermostatistical arguments; Frank et al., 2012) and assume first
order kinetics for translation and degradation rates. Therewith a
dynamic model of gene expression is described as
d
dt
x = ksynt u
n
K n + un − kdegx ,
d
dt
y = psyntx − pdegy ,
where u denotes the concentration of upstream kinase activity,
x and y denote mRNA and protein concentrations, respectively,
and ksynt, K, n, kdeg, psynt, and pdeg are kinetic parameters. Many
of these parameters can be fixed based on biologically reasonable
assumptions and kinetic data available in the literature.
The half life of several unmodified DUSP proteins were
reported as being between 20 and 45 min (DUSP1, 4, 5, 6, 16).
However, following posttranslational regulation by phosphory-
lation and ubiquitination, these half lives ranged from as short
as 7.5 min to as long as 4 h (Katagiri et al., 2005; Kucharska
et al., 2009; Cagnol and Rivard, 2012). The half live of DUSP6
mRNA was reported as being between 20 and 40 min, which
decreased to as little as 8 min following the inhibition of basal
MEK activity (Bermudez et al., 2011). Neglecting this complex-
ity, the model assumes equal half lives for protein and mRNA at
a value of 30 min for all phosphatases, which fixes the degrada-
tion parameters according to kdeg= pdeg= log (2)/(30 min). Fur-
ther, the model assumes a 10-fold amplification from the mRNA
level to the protein level, fixing the protein synthesis parame-
ter according to psynt= 10pdeg. The expression level of mRNA
was normalized (x ≤ 1), which fixes the mRNA synthesis para-
meter at psynt= kdeg. The remaining parameters were chosen
such that for strong, constant activity of the upstream kinase
yields reasonable expression levels of around 80% (x ≈ 0.8) of
the maximal possible value. Further assuming a reasonable degree
of ultrasensitivity n= 2, fixes the threshold of half activation
at K = 0.5.
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